MY iPS Project
The owner, status and timeline of this project. A free account opens every field.
Source: Evrim Ağacı
Kyoto University has launched a new cell manufacturing facility aimed at producing personalized induced pluripotent stem (iPS) cells efficiently and safely. The facility will utilize automated systems to convert patients' own cells into iPS cells, significantly enhancing the accessibility of personalized medical treatments.
- Status
- Under Construction
- Sector
- Hospital, Education, Manufacturing (Industrial)
- Location
- Osaka, Japan
- Updated
- 22 Jul 2026
- Source
- Evrim Ağacı
ConstructChat
Ask ConstructChat about MY iPS Project
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Under Construction |
Taiyo status | Under Construction |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Kyoto University has launched a new cell manufacturing facility aimed at producing personalized induced pluripotent stem (iPS) cells efficiently and safely. The facility will utilize automated systems to convert patients' own cells into iPS cells, significantly enhancing the accessibility of personalized medical treatments. |
Original sector | Healthcare |
Budget |
Location
Country | Japan |
State | Osaka |
City | Osaka |
Source
Source | Evrim Ağacı |
URL |
More Details
Record type | Project |
Sector | Hospital, Education, Manufacturing (Industrial) |
Article published date | 2025-03-23 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Japan
- Camp Zama
- Shonan Research Center
- Sumitomo Pharmaceutical Manufacturing Plant, Ibaraki City, Japan
- Daiichi Asubio Pharma New Bio Plant (NBP), Gunma Prefecture
- Chugai Pharmaceutical Antibody API Manufacturing Plant, Tokyo, Japan
- Chugai Pharmaceutical Bulk Antibody
- Taiyo Pharmaceutical Industry, Contract Manufacturing Plant
- Astellas Pharma’s New Manufacturing Facility, Toyama
